Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
With AI demand driving up energy demand, will sustainability efforts be enough?
Northvolt blamed supply chain kinks caused by geopolitical instability, along with shifting EV demand, for its demise.
Last year, the airline announced plans to do away with another uniquely Southwest policy: its open, no-assigned-seats boarding policy.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Tesla’s stock closed down for a record seventh consecutive week on Friday, and has nearly erased a $700 billion post-election rally.
A slew of retail company earnings reports last week raised the spectre of sapped spending as executives discussed tariffs.
The Lone Star state has emerged, by a long shot, as the nation’s leader in renewable energy generation, according to new data.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Novo Nordisk will sell its blockbuster weight-loss drug Wegovy for under half its normal price via a new direct-to-consumer online pharmacy.
Policies floated by European Union leaders that could boost the bloc’s defense spending have sent the company’s shares flying.
Prada reported retail sales across its brands rose 18% last year as the company reportedly gears up to buy Versace from Capri Holdings.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.